课题基金 / 基金详情

Chemokine Network and HIV-1 Pathogenesis: Phenotypic and Functional Characterization of New Th17 Subsets Permissive versus Resistant to Viral Infection

Chemokine Network and HIV-1 Pathogenesis: Phenotypic and Functional Characterization of New Th17 Subsets Permissive versus Resistant to Viral Infection
趋化因子网络和 HIV-1 发病机制：允许与抵抗病毒感染的新 Th17 亚群的表型和功能特征
批准号：
225297
负责人：
Ancuta Petronela
金额：
$53.1万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=225297&lang=en
关键词：
Antiviral Immunity Chemokines/Chemokine Receptors Genome Wide Analysis Of Gene Expression Hiv Replication And Viral Reservoirs Hiv Restriction And Permissiveness Factors Polychromatic Flow Cytometry Analysis And Sorting Real Time Pcr And Rt-Pcr Rna

项目摘要

项目成果

Ancuta Petronela的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human immunodeficiency virus type 1 (HIV) establishes a lethal infection by mechanisms that are not clearly understood and viral eradication is not achieved under the current antiretroviral therapies (ART). HIV infection is associated with a rapid dep
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding the Perfect Time to Hunt for HIV: A Tale of 36 Hours at the CHUM
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
海外基金